Stone Summit Wealth’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Stone Summit Wealth's GILD Position: Q3 2026 in Review
Stone Summit Wealth reduced its Gilead Sciences (GILD) stake by 11% in Q3 2026, selling an estimated $488K and leaving 27,189 shares worth $4.05M. The position accounts for 1.09% of the portfolio, ranked #30.
Stone Summit Wealth first reported a position in GILD in Q4 2021 and has held it in 20 quarters since. The position peaked at $4.35M in Q1 2026. 785 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Stone Summit Wealth held 27,189 shares of Gilead Sciences worth $4.05M as of Q3 2026.
- Stone Summit Wealth sold 3,480 Gilead Sciences shares in Q3 2026, an estimated $488K.
- Gilead Sciences made up 1.09% of Stone Summit Wealth's portfolio in Q3 2026, its #30 holding.
- Stone Summit Wealth first reported a position in Gilead Sciences in Q4 2021 and has held it in 20 quarters since.
- Stone Summit Wealth's Gilead Sciences position peaked at $4.35M in Q1 2026.
- 785 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Stone Summit Wealth's 13F filing for Q3 2026, filed 14 Oct 2026.